Form 4 for EW Edwards Lifesciences
Accepted 2025-12-09 00:00:00 ET · period of report 2025-12-09 · accession 0001225208-25-009797 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-09 | 2025-12-09 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $59.26 | +7,700 | 47.6K | +19% | +$456.3K |
| D | 2025-12-09 | 2025-12-09 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $84.47 | -7,700 | 39.9K | -16% | -$650.4K |
| D | 2025-12-09 | 2025-12-09 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $0.00 | -7,700 | 39.0K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-09 | M | A | 7,700 | $59.26 | 47,598 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-09 | S | D | 7,700 | $84.47 | 39,898 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $84.09 to $85.07. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2025-12-09 | M | D | 7,700 | $0.00 | 39,000 | D | $59.26 · 2020-05-08 to 2026-05-07 | 7,700 Common Stock |